SKA1 and central nervous system cancer: Furthermore, the K-M curve analysis of SKA complex in patients with gliomas included in the GEPIA database demonstrated that the patients with gliomas who have higher expressions of SKA1 and SKA3 tend to have shorter OS than those with lower expression (p < 0.01; Figures 5A,C).